Epinephrine- and thrombin-stimulated high-affinity GTPase activity in platelet membranes from patients with psychiatric disorders

Psychiatry Research

Volumn 112, Issue 2, 2002, Pages 111-119

  Odagaki, Yuji ^a,b   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

2A Adrenergic receptor; Blood platelets; G protein; Mood disorder; Schizophrenia; Thrombin receptor

Indexed keywords

ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; ISOPROTEIN; THROMBIN; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; THROMBOCYTE MEMBRANE;

ADULT; BIPOLAR DISORDER; BLOOD PLATELETS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; NEUROTIC DISORDERS; NOREPINEPHRINE; PSYCHOPATHOLOGY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, THROMBIN; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0037057966     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00189-0     Document Type: Article

References (40)

1. Avissar S., Barki-Harrington L., Nechamkin Y., Roitman G., Schreiber G. Reduced β-adrenergic receptor-coupled Gs protein function and Gsα immunoreactivity in mononuclear leukocytes of patients with depression. Biological Psychiatry. 39:1996;755-760.
2. Avissar S., Nechamkin Y., Barki-Harrington L., Roitman G., Schreiber G. Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. Journal of Affective Disorders. 43:1997;85-93.
3. Avissar S., Nechamkin Y., Roitman G., Schreiber G. Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression. American Journal of Psychiatry. 154:1997;211-217.
4. Avissar S., Nechamkin Y., Roitman G., Schreiber G. Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression. American Journal of Psychiatry. 155:1998;666-671.
5. q family. FEBS Letters. 363:1995;49-52.
6. Birnbaumer L., Abramowitz J., Brown A.M. Receptor-effector coupling by G proteins. Biochimica et Biophysica Acta. 1031:1990;163-224.
7. Coppen A.J. Biochemical aspects of depression. International Psychiatic Clinics. 6:1969;53-81.
8. Elliott J.M. Peripheral markers in affective disorders. Horton R.W., Katona C.L.E., Biological Aspects of Affective Disorders. 1991;95-144 Academic Press, London.
9. 2-adrenoceptor-mediated platelet aggregation in patients with major depressive disorder. European Journal of Pharmacology. 94:1983;359-360.
10. 2-adrenoceptors in major affective disorder. Archives of General Psychiatry. 43:1986;51-57.
11. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Archives of General Psychiatry. 47:1990;125-132.
12. i2 subunit and down-regulation by antidepressant drug treatment. Biological Psychiatry. 42:1997;704-712.
13. Gilman A.G. G proteins: transducers of receptor-generated signals. Annual Review of Biochemistry. 56:1987;615-649.
14. Grandt R., Aktories K., Jakobs K.H. Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochemical Journal. 237:1986;669-674.
15. Hepler J.R., Gilman A.G. G proteins. Trends in Biochemical Sciences. 17:1992;383-387.
16. Houslay M.D., Bojanic D., Gawler D., O'Hagan S., Wilson A. Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets. Biochemical Journal. 238:1986;109-113.
17. Hudson C.J., Young L.T., Li P.P., Warsh J.J. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse. 13:1993;278-293.
18. Kafka M.S., Siever L.J., Nurnberger J.I., Uhde T.W., Targum S., Cooper D.M.J., van Kammen D.P., Tokala N.S. Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia. Psychopharmacology Bulletin. 21:1985;599-602.
19. 2-adrenergic receptor function in patients with unipolar and bipolar affective disorders. Journal of Affective Disorders. 10:1986;163-169.
20. 2-adrenergic receptor function in psychiatric disorders. Psychiatry Research. 23:1988;11-22.
21. Karege F., Bovier P., Rudolph W., Gaillard J.-M. Platelet phosphoinositide signaling system: an overstimulated pathway in depression. Biological Psychiatry. 39:1996;697-702.
22. Karege F., Bovier P., Stepanian R., Gaillard J.-M. Change in platelet GTP-binding protein in drug-free depressed patients. Human Psychopharmacology. 11:1996;115-121.
23. Karege F., Bovier P., Widmer J., Gaillard J.-M., Tissot R. Decrease in epinephrine-induced attenuation of platelet adenylate cyclase activity in depressed patients: relationship with plasma electrolytes. Neuropsychobiology. 26:1992;129-135.
24. 2-adrenergic receptor activity in clinical studies of depression. Usdin E., Goldstein M., Friedhoff A.J., Georgotas A., Frontiers in Neuropsychiatric Research. 1983;331-356 Macmillan Press, London.
25. Manji H.K. G proteins: implications for psychiatry. American Journal of Psychiatry. 149:1992;746-760.
26. Mikuni M., Kusumi I., Kagaya A., Kuroda Y., Mori H., Takahashi K. Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry. 15:1991;49-61.
27. Mikuni M., Kagaya A., Takahashi K., Meltzer H.Y. Serotonin- but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology. 106:1992;311-314.
28. Mooney J.J., Schatzberg A.F., Cole J.O., Kizuka P.P., Salomon M., Lerbinger J., Pappalardo K.M., Gerson B., Schildkraut J.J. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biological Psychiatry. 23:1988;543-559.
29. Mori H., Koyama T., Yamashita I. Platelet alpha-2 adrenergic receptor-mediated phosphoinositide responses in endogenous depression. Life Sciences. 48:1991;741-748.
30. Murphy D.L., Donnelly C., Moskowitz J. Catecholamine receptor function in depressed patients. American Journal of Psychiatry. 131:1974;1389-1391.
31. 32P]ADP-ribosylation in human platelet membranes: negative correlation with age. Life Sciences. 50:1992;1851-1857.
32. Odagaki Y., Koyama T., Yamashita I. Pharmacological characterization of epinephrine-stimulated GTPase activity in human platelet membranes. Biochemical Pharmacology. 46:1993;2021-2028.
33. Odagaki Y., Koyama T., Yamashita I. Platelet pertussis toxin-sensitive G proteins in affective disorders. Journal of Affective Disorders. 31:1994;173-177.
34. Odagaki Y., Nishi N., Koyama T. Lack of interfering effects of lithium on receptor/G protein coupling in human platelet and rat brain membranes. Biological Psychiatry. 42:1997;697-703.
35. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry. 122:1965;509-522.
36. Schreiber G., Avissar S., Danon A., Belmaker R.H. Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biological Psychiatry. 29:1991;273-280.
37. Siever L.J., Kafka M.S., Targum S., Lake C.R. Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Research. 11:1984;287-302.
38. Spiegel A.M., Weinstein L.S., Shenker A. Abnormalities in G protein-coupled signal transduction pathways in human disease. Journal of Clinical Investigation. 92:1993;1119-1125.
39. Wang Y.-C., Pandey G.N., Mendels J., Frazer A. Platelet adenylate cyclase responses in depression: implications for a receptor defect. Psychopharmacologia (Berlin). 36:1974;291-300.
40. Wood K., Swade C., Coppen A. Platelet α-adrenergic receptors in depression: ligand binding and aggregation studies. Acta Pharmacologica et Toxicologica. 56 (Supplement 1):1985;203-211.